Dr. Moreau - A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma
Philippe Moreau, MD
University Hospital
Nantes, France
12.02.10
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
button next to the volume control in the
lower right hand corner.
print
related articles